Clinical Study
Clinical Usefulness of Cancer Markers in Primary Breast Cancer
Table 3
Sensitivity of tumor markers in primary breast cancer in stages T1– T4.
| | CA 549 | MSA | CA 15-3 |
| | Sensitivity () | 33% | 18% | 35% | | Sen. T1-Stage () | 35% | 8% | 15% | | Sen. T2-Stage () | 33% | 22% | 48% | | Sen. T3-Stage () | 25% | 25% | 0% | | Sen. T4-Stage () | 33% | 33% | 83% | | Specificity () | 90% | 96% | 89% | | Cutoff | 12,6 U/mL | 55 U/mL | 25 U/mL |
|
|
